Beta
Back to JNJ.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
cash-flow-chart

JNJ Cash Flow

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q1'26, Johnson & Johnson's Operating Cash Flow reached $2.51B USD, reflecting a notable decline from the previous quarter's $7.31B USD in Q4'25, while Free Cash Flow stood at $1.47B USD, down from $5.47B USD in Q4'25, indicating potential pressures from capital expenditures or seasonal factors. Over the period from Q2'23 to Q1'26, Operating Cash Flow exhibited volatility with peaks in Q3'24 ($7.99B USD) and Q3'25 ($9.17B USD), alongside consistent first-quarter dips below $4.2B USD, suggesting cyclical patterns tied to operational cycles; Free Cash Flow followed a similar trajectory, averaging around 80-85% of operating cash flow annually, with an overall upward trend in peak quarters but recent softening in early 2026 pointing to moderating growth amid broader economic influences.